BOKF, NA - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOKF, NA ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$800
-84.3%
10,0000.0%0.00%
Q2 2023$5,100
-19.0%
10,0000.0%0.00%
Q1 2023$6,300
-2.9%
10,0000.0%0.00%
Q4 2022$6,491
-61.8%
10,0000.0%0.00%
Q3 2022$17,000
+41.7%
10,0000.0%0.00%
Q2 2022$12,000
+71.4%
10,0000.0%0.00%
Q1 2022$7,000
-36.4%
10,0000.0%0.00%
Q4 2021$11,000
-52.2%
10,000
-21.2%
0.00%
Q3 2021$23,000
-36.1%
12,697
+27.0%
0.00%
-100.0%
Q1 2021$36,000
+44.0%
10,0000.0%0.00%
Q4 2020$25,0000.0%10,0000.0%0.00%
-100.0%
Q3 2020$25,000
-24.2%
10,0000.0%0.00%0.0%
Q2 2020$33,000
+32.0%
10,0000.0%0.00%0.0%
Q1 2020$25,000
-46.8%
10,0000.0%0.00%0.0%
Q4 2019$47,000
+9.3%
10,0000.0%0.00%0.0%
Q3 2019$43,000
-25.9%
10,0000.0%0.00%0.0%
Q2 2019$58,000
+48.7%
10,0000.0%0.00%0.0%
Q1 2019$39,000
+105.3%
10,0000.0%0.00%0.0%
Q4 2018$19,000
-40.6%
10,0000.0%0.00%0.0%
Q3 2018$32,000
+6.7%
10,0000.0%0.00%0.0%
Q2 2018$30,000
-23.1%
10,0000.0%0.00%0.0%
Q1 2018$39,000
-4.9%
10,0000.0%0.00%0.0%
Q4 2017$41,000
-32.8%
10,0000.0%0.00%
-50.0%
Q3 2017$61,000
-1.6%
10,0000.0%0.00%0.0%
Q2 2017$62,000
-1.6%
10,0000.0%0.00%0.0%
Q1 2017$63,000
+16.7%
10,0000.0%0.00%0.0%
Q4 2016$54,000
-5.3%
10,000
-0.6%
0.00%0.0%
Q3 2016$57,00010,0640.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders